Clara Pharmachem Pvt. Ltd. specializes in the development and manufacturing of high-quality pharmaceutical intermediates that serve as vital building blocks for advanced APIs and complex formulations. Each intermediate is produced under tightly controlled conditions to ensure high purity, reproducibility, and regulatory compliance for downstream pharmaceutical synthesis.
Below is the list of Intermediates manufactured and supplied by the company.
| Product Name | CAS Number | Intermediate For |
|---|---|---|
| Ethyl-4-Bromobutyrate | 2969-81-5 | Elagolix |
| 4-Amino-1-Butanol | 13325-10-5 | Selexipag |
| N-Naphthyl Ethylenediamine Dihydrochloride | 1465-25-4 | Analytical Determination |
| D-Mandelic Acid | 611-72-3 | General Intermediate & Chiral Synthesis |
| 1-Bromo Naphthalene | 90-11-9 | Aromatic Intermediate & Specialty Chemicals |
| N-Octyl Benzene | 2189-60-8 | Organic Intermediate for Fine Chemicals |
| 4-Chlorobutyl Acetate | 6962-92-1 | Aromatic Intermediates |
Clara Pharmachem Pvt. Ltd. maintains a robust infrastructure dedicated to the production of pharmaceutical intermediates that adhere to global standards of safety, quality, and consistency. Every synthesis process is optimized by experienced chemists and validated through stringent analytical protocols. Controlled environments, validated equipment, and continuous in-process checks ensure that each intermediate exhibits reproducible quality and chemical integrity.
The company’s facilities are managed under strictly controlled quality systems, supported by dedicated Quality Assurance (QA) and Quality Control (QC) laboratories equipped with advanced analytical instruments such as HPLC, GC, and IR spectrophotometers. Every production stage—from raw material evaluation to in-process analysis and final packaging—is carefully monitored, documented, and traceable. Comprehensive testing, including stability assessment, impurity profiling, and specification verification, forms an integral part of the company’s quality release procedures, ensuring that each product consistently meets both international quality expectations and client-specific requirements.
Driven by innovation and guided by regulatory discipline, Clara Pharmachem Pvt. Ltd. continues to expand its capabilities in the field of pharmaceutical intermediates. The company’s commitment to R&D and process optimization allows it to consistently deliver intermediates that enable efficient downstream synthesis and cost-effective scalability. By combining scientific rigor with a client-focused approach, Clara Pharmachem stands as a dependable partner to global pharmaceutical companies seeking excellence, reliability, and long-term collaboration.